Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2002

View Archived Issues

Novel diazoxide analogue preserves beta-cell function

TLK-19780, a nonpeptide insulin receptor activator

Glucose concentration-dependent insulin secretion potentiators identified at Kyowo Hakko

AndroGel continues to provide benefits in hypogonadal men for up to 42 months

MMP-targeting NeuGene antisense agent inhibits prostate cancer growth

Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor effective in type 2 diabetes model

GW-3965, a synthetic LXR ligand, displays potent antiatherogenic activity

Antiinflammatory activity of IS-741 in experimental colitis

Australia first to approve Xolair

Potent in vitro activity of ravuconazole and voriconazole against Candida spp.

Inflazyme reports on development of key LSAIDs

Cytovax updates progress of key product candidates

Synthesis and therapeutic applications of glucocorticoid receptor modulators

Plexus Vaccine establishes subsidiary for new vaccine development

Celgene and Novartis advance SERM osteoporosis program

Genelabs permitted to seek E.U. approval for Aslera under centralized procedure

Tanox outlicenses Bak gene

Xenerex awarded funding for development of anthrax therapy

UCB presents R&D overview

New agents for HIV identified at Parker Hughes Institute

Recent patent covers new PDE5 inhibitors designed at Lilly Icos

Novartis presents new PKC inhibitors and use in autoimmune diseases, cancer, etc.

Pyrimidine NPY receptor antagonists useful for obesity

Calcilytic compounds in development at GSK for osteoporosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...